Anticipating resistance to KRAS inhibition: a novel role for USP21 in macropinocytosis regulation
Crawford HC. Anticipating resistance to KRAS inhibition: a novel role for USP21 in macropinocytosis regulation. Genes Dev 2021; 35(19-20):1325-1326.
Genes & development
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Virtually all PDAC harbors an oncogenic mutation in the KRAS gene, making it the prime target for therapy. Most previous attempts to inhibit KRAS directly have been disappointing, but recent success in targeting some KRAS mutants presages a new era in PDAC therapy. Models of PDAC have predicted that identifying KRAS inhibitor resistance mechanisms will be critical. In this issue of Genes & Development, Hou and colleagues (pp. 1327-1332) identify one such mechanism in which the deubiquitinase USP21 up-regulates the nutrient-scavenging process of macropinocytosis, rescuing PDAC cells from Kras extinction.